Evidence map›Paper›PMID 30625315›Full record

ArticleCell reports2019

Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP

Eugen Brailoiu, Sumita Chakraborty, G Cristina Brailoiu, Pingwei Zhao, Jeffrey L Barr, Marc A Ilies, Ellen M Unterwald, Mary E Abood, Colin W Taylor

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Choline-An Essential Nutrient with Health Benefits and a Signaling Molecule.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Modulation of the Blood-Brain Barrier by Sigma-1R Activation.International journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Development of a Novel σACS chemical neuroscience · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Eugen BrailoiuCenter for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. Electronic address: ebrailou@temple.edu.
Sumita ChakrabortyDepartment of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK.
G Cristina BrailoiuDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Pingwei ZhaoCenter for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Jeffrey L BarrCenter for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Marc A IliesDepartment of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA.
Ellen M UnterwaldCenter for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Mary E AboodCenter for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Colin W TaylorDepartment of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK. Electronic address: cwt1000@cam.ac.uk.
Temple University · USLawn Tennis Association · GBJefferson College · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Munir Gunes Kutlu · 2000 to 2026
$34.6M
Functional Role for GPR55 in the periaqueductal grayR01DA035926 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ABOOD, MARY E, BENAMAR, KHALID · 2014 to 2018
$1.6M
Modulation of the Blood-Brain Barrier by Novel Cannabinoid ReceptorsR03NS099957 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI BRAILOIU, GABRIELA CRISTINA · 2018 to 2019
$156k
NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA035926NINDS NIH HHS R03 NS099957Wellcome Trust 101844
6 · The paper itself

Abstract

Sigma-1 receptors (Sig-1Rs) are integral ER membrane proteins. They bind diverse ligands, including psychoactive drugs, and regulate many signaling proteins, including the inositol 1,4,5-trisphosphate receptors (IP

Indexed as

Calcium SignalingAnimalsCell LineCholineHumansInositol 1,4,5-Trisphosphate ReceptorsMCF-7 CellsMicePhospholipase DReceptors, sigmaSigma-1 ReceptorCholineInositol 1,4,5-Trisphosphate ReceptorsPhospholipase DReceptors, sigmaSigma-1 ReceptorbradykininCa(2+)cholineG-protein-coupled receptorintracellular messengerIP(3) receptorneurotransmitterphospholipase Cphospholipase DSigma-1 receptor

Identifiers

PMID30625315
PMCPMC6326163
OpenAlexW2909934293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.